# The Emerging Risks of Modern Cannabis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/the-emerging-risks-of-modern-cannabis/ > **Published:** 2026-07-07T17:18:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:58:37-04:00 > **Clinical Summary:** High-potency cannabis poses emerging risks for dependence, psychosis, and hyperemesis. Learn clinical screening and counseling strategies. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafety[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)THCCBDAnxietyNeurology Why This Matters Clinicians need to assess [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) frequency in patients taking biologic therapies, as emerging evidence suggests cannabis may interact with inflammatory pathways that these medications target. Understanding these potential interactions is critical for optimizing treatment outcomes in patients with inflammatory conditions who use cannabis. Routine screening for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns should become standard practice when prescribing immunomodulatory medications. Clinical Summary # Summary This article examines emerging health risks associated with contemporary [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), highlighting the importance of clinicians understanding evolving safety profiles beyond traditional concerns. Modern cannabis products, particularly high-potency formulations, have been linked to increased inflammatory markers and may interact with biologic therapies commonly used in rheumatologic and immunologic conditions. The structured assessment approach described in the article—capturing frequency and patterns of cannabis use—provides a practical framework for clinical intake that can inform risk stratification and [treatment planning](https://cedclinic.com/regional-access-hubs-medical-cannabis-livermore-falls/). Given the growing prevalence of cannabis use among patients with chronic inflammatory conditions, clinicians should routinely inquire about cannabis consumption and remain alert to potential adverse interactions with immunosuppressive or biologic medications. Clinicians should integrate cannabis use assessment into standard history-taking and consider counseling patients about inflammation risks, particularly those on anti-inflammatory therapies where cannabis-induced inflammation could undermine [treatment efficacy](https://cedclinic.com/clinical-research-treatment-efficacy-medicinal-cannabis-study/). Clinical Perspective 💊 The shifting potency and composition of modern cannabis products—particularly high-THC concentrates and novel cannabinoids—present evolving clinical considerations that differ meaningfully from historical cannabis use patterns. Healthcare providers should recognize that patient self-reported cannabis use may not capture the actual dose, formulation, or frequency of exposure, making it challenging to establish clear causal relationships between cannabis and specific adverse outcomes. The intersection of cannabis use with chronic inflammatory conditions and biologic therapies warrants careful attention, as emerging evidence suggests potential interactions with immune-modulating treatments, though mechanistic understanding remains incomplete. When taking cannabis use histories, clinicians should inquire specifically about product type, concentration, and consumption method rather than relying solely on frequency data, and should counsel patients on potential risks particularly if they are using immunosuppressive therapies. Integrating structured cannabis use assessment into standard clinical workflows—with attention to modern product characteristics—may help clinicians better identify patients at 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20Emerging%20Risks%20of%20Modern%20Cannabis%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D68547)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D68547)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20Emerging%20Risks%20of%20Modern%20Cannabis%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D68547)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Cannabis as Medicine: A Brief History of Humans Using a Plant While Pretending It’s Dangerous](https://cedclinic.com/cannabis-as-medicine-a-brief-history-of-humans-using-a-plant-while-pretending-its-dangerous/) - [The Joint of 2026 Has Almost Nothing in Common With the One From 1976](https://cedclinic.com/the-joint-of-2026-has-almost-nothing-in-common-with-the-one-from-1976/) - [7 unexpected takeaways from the newest research on cannabis and brain effects](https://cedclinic.com/7-unexpected-takeaways-from-the-newest-research-on-cannabis-and-brain-effects/) 📰 Source: [https://www.pharmacytimes.com/view/the-emerging-risks-of-modern-cannabis](https://www.pharmacytimes.com/view/the-emerging-risks-of-modern-cannabis) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).